We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$163M
AUM Growth
-$31.4M
Cap. Flow
-$26.2M
Cap. Flow %
-16.06%
Top 10 Hldgs %
55.25%
Holding
39
New
12
Increased
2
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$9.11M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.22M
3
SNPS icon
Synopsys
SNPS
+$8.01M
4
AMP icon
Ameriprise Financial
AMP
+$7.89M
5
MS icon
Morgan Stanley
MS
+$7.49M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$10.3M
2
MRK icon
Merck
MRK
+$9.66M
3
COP icon
ConocoPhillips
COP
+$9.3M
4
CB icon
Chubb
CB
+$9.04M
5
LIN icon
Linde
LIN
+$8.55M

Sector Composition

Rank Sector Weight
1 Financials 24.78%
2 Healthcare 22.52%
3 Technology 17.36%
4 Industrials 16.08%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$123B
$11.3M 6.96%
39,155
-1,901
-5% -$547K
LNG icon
2
Cheniere Energy
LNG
$54.2B
$9.93M 6.09%
59,831
-4,195
-7% -$636K
UNH icon
3
UnitedHealth
UNH
$382B
$9.87M 6.06%
19,550
-923
-5% -$485K
AZO icon
4
AutoZone
AZO
$51.3B
$9.22M 5.66%
4,306
-75
-2% -$163K
AJG icon
5
Arthur J. Gallagher & Co
AJG
$69.1B
$8.97M 5.5%
52,375
+6,875
+15% +$1.22M
COR icon
6
Cencora
COR
$62B
$8.92M 5.47%
65,919
-2,177
-3% -$313K
GS icon
7
Goldman Sachs
GS
$289B
$8.24M 5.06%
+28,129
New +$9.11M
MS icon
8
Morgan Stanley
MS
$319B
$8.19M 5.03%
103,659
+88,882
+601% +$7.49M
PANW icon
9
Palo Alto Networks
PANW
$256B
$7.81M 4.79%
95,398
-5,318
-5% -$461K
AMP icon
10
Ameriprise Financial
AMP
$47.8B
$7.55M 4.63%
+29,970
New +$7.89M
SCHW
11
Charles Schwab
SCHW
$182B
$7.43M 4.56%
+103,450
New +$7.18M
QQQ icon
12
Invesco QQQ Trust
QQQ
$436B
$7.28M 4.47%
+27,244
New +$8.22M
NOC icon
13
Northrop Grumman
NOC
$76B
$7.26M 4.45%
+15,430
New +$7.35M
SNPS icon
14
Synopsys
SNPS
$71.6B
$7.23M 4.43%
+23,655
New +$8.01M
JBHT icon
15
JB Hunt Transport Services
JBHT
$25.9B
$6.67M 4.09%
+42,650
New +$7.45M
TMO icon
16
Thermo Fisher Scientific
TMO
$214B
$6.57M 4.03%
+12,950
New +$7.25M
RTX icon
17
RTX Corp
RTX
$290B
$6.51M 3.99%
79,496
-17,325
-18% -$1.57M
AAPL icon
18
Apple
AAPL
$4.97T
$6.45M 3.96%
46,676
– –
APH icon
19
Amphenol
APH
$185B
$6.14M 3.77%
+183,300
New +$6.66M
ODFL icon
20
Old Dominion Freight Line
ODFL
$46.3B
$5.77M 3.54%
+46,420
New +$6.42M
EIDO icon
21
iShares MSCI Indonesia ETF
EIDO
$466M
$1.76M 1.08%
75,478
-7,602
-9% -$177K
INDA icon
22
iShares MSCI India ETF
INDA
$6.81B
$1.41M 0.87%
+34,650
New +$1.46M
SE icon
23
Sea Limited
SE
$66.4B
$1.22M 0.75%
21,700
– –
AMAT icon
24
Applied Materials
AMAT
$347B
$662K 0.41%
8,079
– –
VNM icon
25
VanEck Vietnam ETF
VNM
$478M
$572K 0.35%
+43,040
New +$636K
1
2

Similar funds

DM
Delphi Management Brookline, Massachusetts $83.6M AUM 26.67% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $83.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $83.2M AUM
GIA
Goodwin Investment Advisory Woodstock, Georgia $84M AUM 19.62% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
CC
CF Capital Cohasset, Massachusetts $83M AUM 14.05% 1-Year Est. Return
BC
Blantyre Capital London, United Kingdom $82.8M AUM 47.77% 1-Year Est. Return
MIPU
Man Investment Partners (US) New York $84.3M AUM

Marvin & Palmer Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Marvin & Palmer Associates held 39 positions worth $163M, down 16% from $194M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Marvin & Palmer Associates withdrew a net $26.2M in Q3 2022, closing 14 positions and reducing 8 holdings. Its most notable exit was Eli Lilly, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Marvin & Palmer Associates opened a new position in Goldman Sachs worth $8.24M.

  • Marvin & Palmer Associates's largest Q3 2022 buy was Goldman Sachs: 28,129 shares worth $8.24M.
  • Marvin & Palmer Associates added most to Morgan Stanley in Q3 2022, an estimated $7.49M increase.
  • Marvin & Palmer Associates's biggest Q3 2022 reduction was RTX Corp, cutting an estimated $1.57M.
  • Marvin & Palmer Associates fully exited Eli Lilly in Q3 2022, selling an estimated $10.3M.
  • Marvin & Palmer Associates's ten largest holdings make up 55% of its $163M portfolio in Q3 2022.
  • Marvin & Palmer Associates opened 12 new positions and closed 14 in Q3 2022.
  • Marvin & Palmer Associates's portfolio value fell 16% quarter-over-quarter to $163M.

Based on Marvin & Palmer Associates's 13F filing for Q3 2022, filed 14 Nov 2022.